Assignee
VANGUARD THERAPEUTICS INC
US·0 granted patents·2 pending applications·0 citations·filing 2016–2020
Top patents by PatentIndex Score
2 records- 0132US2021220390A1Pentosan polysulfate sodium for the treatment of sickle cell diseaseVANGUARD THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0227US2018318336A1Pentosan polysulfate sodium for the treatment of sickle cell diseaseVANGUARD THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VANGUARD THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →